Opiant Pharmaceuticals Inc (NASDAQ:OPNT)
| 13.00 Delayed Data As of Jul 06 |  +0.20 / +1.56%Today’s Change | 7.34 Today|||52-Week Range 37.71 | -61.34% Year-to-Date |
Latest OPNT News | Press Releases
No recent news for Opiant Pharmaceuticals Inc.
Today’s Trading
| Previous close | 12.80 |
| Today’s open | 12.80 |
| Day’s range | 11.58 - 13.00 |
| Volume | 457 |
| Average volume (3 months) | 81,638 |
| Market cap | $61.3M |
Data as of 3:59pm ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -1,317.65% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +61.30% |
| P/E ratio | NM |
| Price/Sales | 4.17 |
| Price/Book | 1.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRVNTrevena Inc | -0.02 | -5.13% |
| ---- | ||
| --Cortica Neuroscience... | 0.00 | 0.00% |
| ETONEton Pharmaceuticals... | +0.02 | +0.76% |
Data as of 3:59pm ET, 07/06/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$1.37 |
| Annual revenue (last year) | $47.8M |
| Annual profit (last year) | $3.0M |
| Net profit margin | 6.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Santa Monica, California |
Forecasts
